Cleared Special

K022689 - MODIFICATION TO MEDAMICUS AXIA RSN

K022689 is an FDA 510(k) clearance for MODIFICATION TO MEDAMICUS AXIA RSN, manufactured by Medamicus, Inc.. The device is a Class 2 Cardiovascular device with product code DYB cleared through the Special 510(k) pathway after a 10-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2002
Decision
10d
Days
Class 2
Risk

K022689 is an FDA 510(k) clearance for the MODIFICATION TO MEDAMICUS AXIA RSN. Classified as Introducer, Catheter (product code DYB), Class II - Special Controls.

Submitted by Medamicus, Inc. (Minneapolis, US). The FDA issued a Cleared decision on August 23, 2002 after a review of 10 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1340 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medamicus, Inc. devices

FDA 510(k) Submission Details - K022689

510(k) Number K022689 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2002
Decision Date August 23, 2002
Days to Decision 10 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
115d faster than avg
Panel avg: 125d · This submission: 10d
Pathway characteristics
Modification to existing cleared device.

DYB Device Classification - Class 2, Special Controls

Product Code DYB Introducer, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DYB Introducer, Catheter

All 410
Devices cleared under the same product code (DYB) and FDA review panel - the closest regulatory comparables to K022689.
MODIFICATION TO ULTIMUM EV HEMOSTASIS INTRODUCER (22F)
K023447 · St Jude Medical · Oct 2002
MEDCOMP VASCU-SHEATH INTRODUCER SET
K022513 · Medcomp · Oct 2002
TITAN MICRO CATHETER, MODEL 105-5074-153
K022003 · Micro Therapeutics, Inc. · Sep 2002
SHEATH ADAPTER, MODEL SA-09847
K021723 · Arrow Intl., Inc. · Aug 2002
INTROCAN SAFETY IV CATHETER
K021094 · B.Braun Medical, Inc. · Jul 2002
BD INTROSYTE PRECISION INTRODUCER
K020834 · Becton Dickinson Infusion Therapy Systems, Inc. · Jun 2002